Danaher ROA 2010-2025 | DHR

Current and historical return on assets (ROA) values for Danaher (DHR) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Danaher ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2025-03-31 $3.77B $79.12B 4.77%
2024-12-31 $3.90B $77.54B 4.87%
2024-09-30 $3.89B $80.62B 4.76%
2024-06-30 $4.20B $78.56B 5.03%
2024-03-31 $4.40B $83.40B 5.17%
2023-12-31 $4.74B $84.49B 5.54%
2023-09-30 $5.87B $87.73B 6.87%
2023-06-30 $6.30B $84.90B 7.51%
2023-03-31 $6.85B $85.04B 8.24%
2022-12-31 $7.10B $84.35B 8.59%
2022-09-30 $6.64B $81.03B 8.06%
2022-06-30 $6.21B $81.81B 7.50%
2022-03-31 $6.29B $83.39B 7.69%
2021-12-31 $6.27B $83.18B 7.86%
2021-09-30 $5.72B $82.50B 7.33%
2021-06-30 $5.45B $78.03B 7.20%
2021-03-31 $4.60B $75.43B 6.21%
2020-12-31 $3.51B $76.16B 4.85%
2020-09-30 $3.57B $72.89B 5.18%
2020-06-30 $3.37B $71.27B 5.11%
2020-03-31 $3.19B $68.93B 5.19%
2019-12-31 $2.94B $62.08B 5.14%
2019-09-30 $2.43B $61.53B 4.53%
2019-06-30 $2.45B $53.32B 4.88%
2019-03-31 $2.41B $51.77B 4.94%
2018-12-31 $2.65B $47.83B 5.56%
2018-09-30 $2.76B $47.72B 5.83%
2018-06-30 $2.67B $48.06B 5.69%
2018-03-31 $2.55B $47.15B 5.51%
2017-12-31 $2.49B $46.65B 5.44%
2017-09-30 $2.38B $45.85B 5.23%
2017-06-30 $2.20B $45.65B 4.96%
2017-03-31 $2.30B $45.25B 5.02%
2016-12-31 $2.55B $45.30B 5.48%
2016-09-30 $2.50B $41.30B 5.27%
2016-06-30 $3.51B $51.50B 7.09%
2016-03-31 $3.55B $48.39B 7.74%
2015-12-31 $3.36B $48.22B 7.86%
2015-09-30 $3.33B $49.71B 8.34%
2015-06-30 $2.61B $36.99B 7.17%
2015-03-31 $2.59B $36.07B 7.18%
2014-12-31 $2.60B $36.99B 7.26%
2014-09-30 $2.73B $35.54B 7.74%
2014-06-30 $2.64B $35.65B 7.60%
2014-03-31 $2.58B $35.04B 7.57%
2013-12-31 $2.70B $34.67B 8.05%
2013-09-30 $2.54B $33.72B 7.67%
2013-06-30 $2.49B $33.11B 7.65%
2013-03-31 $2.47B $32.47B 7.71%
2012-12-31 $2.39B $32.94B 7.59%
2012-09-30 $2.33B $31.59B 7.58%
2012-06-30 $2.31B $31.17B 7.55%
2012-03-31 $2.36B $30.42B 7.69%
2011-12-31 $2.17B $29.95B 7.55%
2011-09-30 $2.08B $30.62B 7.73%
2011-06-30 $2.20B $31.51B 8.95%
2011-03-31 $1.92B $23.04B 8.85%
2010-12-31 $1.79B $22.22B 8.57%
2010-09-30 $1.59B $21.50B 7.82%
2010-06-30 $1.29B $20.08B 6.56%
2010-03-31 $1.21B $19.88B 6.31%
2009-12-31 $1.15B $19.60B 6.16%
Sector Industry Market Cap Revenue
Medical Medical Services $143.821B $23.875B
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally.
Stock Name Country Market Cap PE Ratio
CVS Health (CVS) United States $84.326B 10.48
Elevance Health (ELV) United States $78.255B 10.10
Cencora (COR) United States $58.178B 20.24
DiDi Global (DIDIY) China $23.485B 24.95
Natera (NTRA) United States $22.086B 0.00
Labcorp Holdings (LH) United States $21.684B 17.59
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.804B 0.00
Solventum (SOLV) United States $12.836B 13.59
CochLear (CHEOY) Australia $12.824B 0.00
ICON (ICLR) Ireland $12.156B 11.30
Revvity (RVTY) United States $11.802B 20.31
Viatris (VTRS) United States $10.833B 3.72
Avantor (AVTR) United States $9.247B 13.44
Medpace Holdings (MEDP) United States $9.225B 24.50
HealthEquity (HQY) United States $8.646B 37.87
Sonic Healthcare (SKHHY) Australia $8.518B 0.00
Charles River Laboratories (CRL) United States $7.808B 15.30
Caris Life Sciences,�Inc (CAI) United States $6.930B 0.00
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.971B 29.27
BrightSpring Health Services (BTSG) United States $3.760B 34.50
Sotera Health (SHC) United States $3.296B 18.73
Surgery Partners (SGRY) United States $2.870B 37.32
Alignment Healthcare (ALHC) United States $2.750B 0.00
GeneDx Holdings (WGS) United States $2.622B 100.97
Concentras Parent (CON) United States $2.619B 15.13
Organon (OGN) United States $2.576B 2.74
Progyny (PGNY) United States $2.038B 44.87
Ardent Health (ARDT) United States $1.981B 8.45
PACS (PACS) United States $1.957B 0.00
Premier (PINC) United States $1.778B 13.49
GoodRx Holdings (GDRX) United States $1.739B 34.79
Teladoc Health (TDOC) United States $1.553B 0.00
Establishment Labs Holdings (ESTA) $1.303B 0.00
Pediatrix Medical (MD) United States $1.165B 8.86
CareDx (CDNA) United States $1.129B 17.64
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
Agilon Health (AGL) United States $0.948B 0.00
QDM (QDMI) Hong Kong, SAR China $0.846B 0.00
AMN Healthcare Services Inc (AMN) United States $0.833B 7.80
Nutex Health (NUTX) United States $0.643B 9.73
Embecta (EMBC) United States $0.619B 4.17
InnovAge Holding (INNV) United States $0.571B 0.00
SBC Medicals (SBC) United States $0.546B 0.00
LifeMD (LFMD) United States $0.535B 0.00
Sonida Senior Living (SNDA) United States $0.484B 0.00
Auna S.A (AUNA) Luxembourg $0.471B 10.62
So-Young (SY) China $0.440B 0.00
Omada Health (OMDA) $0.434B 0.00
Enhabit (EHAB) United States $0.368B 30.29
Performant Healthcare (PHLT) United States $0.335B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.330B 0.00
Beauty Health (SKIN) United States $0.263B 0.00
Oncology Institute (TOI) United States $0.216B 0.00
DocGo (DCGO) United States $0.159B 26.00
Pheton Holdings (PTHL) China $0.132B 0.00
Sera Prognostics (SERA) United States $0.100B 0.00
KindlyMD (NAKA) United States $0.074B 0.00
Basel Medical Group (BMGL) Singapore $0.067B 0.00
IceCure Medical (ICCM) Israel $0.062B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
ModivCare (MODV) United States $0.060B 0.00
Biodesix (BDSX) United States $0.046B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.037B 0.00
OSR Holdings (OSRH) United States $0.024B 0.00
Intelligent Bio Solutions (INBS) United States $0.013B 0.00
BioNexus Gene Lab (BGLC) $0.010B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
SeaStar Medical Holding (ICU) United States $0.008B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00